Menactra FDA Approval History
FDA Approved: Yes (First approved January 14, 2005)
Brand name: Menactra
Generic name: meningococcal conjugate vaccine
Company: Sanofi Pasteur
Treatment for: Meningococcal Meningitis Prophylaxis
Menactra (meningococcal conjugate vaccine) is a quadrivalent conjugate vaccine indicated for the prevention of meningococcal disease.
Development timeline for Menactra
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.